Bartlett DL - Search Results

1

Inhibitors of C5 complement enhance vaccinia virus oncolysis.

Magge D, Guo ZS, O'Malley ME, Francis L, Ravindranathan R, Bartlett DL. Magge D, et al. Among authors: bartlett dl. Cancer Gene Ther. 2013 Jun;20(6):342-50. doi: 10.1038/cgt.2013.26. Epub 2013 May 10. Cancer Gene Ther. 2013. PMID: 23661042 Free PMC article.

2

Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.

Puhlmann M, Brown CK, Gnant M, Huang J, Libutti SK, Alexander HR, Bartlett DL. Puhlmann M, et al. Among authors: bartlett dl. Cancer Gene Ther. 2000 Jan;7(1):66-73. doi: 10.1038/sj.cgt.7700075. Cancer Gene Ther. 2000. PMID: 10678358

3

Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression.

McCart JA, Puhlmann M, Lee J, Hu Y, Libutti SK, Alexander HR, Bartlett DL. McCart JA, et al. Among authors: bartlett dl. Gene Ther. 2000 Jul;7(14):1217-23. doi: 10.1038/sj.gt.3301237. Gene Ther. 2000. PMID: 10918490

4

Vaccinia as a vector for gene delivery.

Guo ZS, Bartlett DL. Guo ZS, et al. Among authors: bartlett dl. Expert Opin Biol Ther. 2004 Jun;4(6):901-17. doi: 10.1517/14712598.4.6.901. Expert Opin Biol Ther. 2004. PMID: 15174972 Review.

5

Targeting vaccinia to solid tumors with local hyperthermia.

Chang E, Chalikonda S, Friedl J, Xu H, Phan GQ, Marincola FM, Alexander HR, Bartlett DL. Chang E, et al. Among authors: bartlett dl. Hum Gene Ther. 2005 Apr;16(4):435-44. doi: 10.1089/hum.2005.16.435. Hum Gene Ther. 2005. PMID: 15871675

6

The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2.

Guo ZS, Naik A, O'Malley ME, Popovic P, Demarco R, Hu Y, Yin X, Yang S, Zeh HJ, Moss B, Lotze MT, Bartlett DL. Guo ZS, et al. Among authors: bartlett dl. Cancer Res. 2005 Nov 1;65(21):9991-8. doi: 10.1158/0008-5472.CAN-05-1630. Cancer Res. 2005. PMID: 16267024

7

Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates.

Naik AM, Chalikonda S, McCart JA, Xu H, Guo ZS, Langham G, Gardner D, Mocellin S, Lokshin AE, Moss B, Alexander HR, Bartlett DL. Naik AM, et al. Among authors: bartlett dl. Hum Gene Ther. 2006 Jan;17(1):31-45. doi: 10.1089/hum.2006.17.31. Hum Gene Ther. 2006. PMID: 16409123

8

High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.

Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HJ 3rd. Popovic PJ, et al. Among authors: bartlett dl. J Immunol. 2006 Dec 15;177(12):8701-7. doi: 10.4049/jimmunol.177.12.8701. J Immunol. 2006. PMID: 17142771

9

A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.

Yang S, Guo ZS, O'Malley ME, Yin X, Zeh HJ, Bartlett DL. Yang S, et al. Among authors: bartlett dl. Gene Ther. 2007 Apr;14(8):638-47. doi: 10.1038/sj.gt.3302914. Epub 2007 Feb 1. Gene Ther. 2007. PMID: 17268533

10

Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy.

Hu W, Davis JJ, Zhu H, Dong F, Guo W, Ang J, Peng H, Guo ZS, Bartlett DL, Swisher SG, Fang B. Hu W, et al. Among authors: bartlett dl. Cancer Biol Ther. 2007 Nov;6(11):1773-9. doi: 10.4161/cbt.6.11.4855. Epub 2007 Aug 12. Cancer Biol Ther. 2007. PMID: 17986853 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters